Central Pharmaceuticals Ltd. (DSE:CENTRALPHL)
Bangladesh
· Delayed Price · Currency is BDT
9.40
-0.40 (-4.08%)
At close: Dec 4, 2025
Central Pharmaceuticals Ratios and Metrics
Market cap in millions BDT. Fiscal year is July - June.
Millions BDT. Fiscal year is Jul - Jun.
| Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Dec '25 Dec 3, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 | Jun '20 Jun 30, 2020 |
| Market Capitalization | 1,126 | 2,168 | 1,486 | 1,569 | 1,581 | 1,593 | |
| Market Cap Growth | 10.59% | 45.97% | -5.34% | -0.76% | -0.75% | 5.56% | |
| Enterprise Value | 1,393 | 2,454 | 1,752 | 1,818 | 1,803 | 1,818 | |
| Last Close Price | 9.40 | 18.10 | 12.40 | 13.10 | 13.20 | 13.30 | |
| PS Ratio | 160.44 | 73.26 | 50.65 | 60.37 | 10.67 | 11.37 | |
| PB Ratio | 1.33 | 2.57 | 2.22 | 2.20 | 2.02 | 2.02 | |
| P/TBV Ratio | 1.33 | 2.57 | 2.22 | 2.20 | 2.02 | 2.02 | |
| P/FCF Ratio | - | 731.27 | - | - | - | - | |
| P/OCF Ratio | 458.35 | 731.27 | - | - | 880.40 | - | |
| EV/Sales Ratio | 198.51 | 82.90 | 59.75 | 69.92 | 12.17 | 12.97 | |
| EV/EBITDA Ratio | - | - | - | - | 45.42 | - | |
| EV/EBIT Ratio | - | - | - | - | 264.59 | - | |
| EV/FCF Ratio | - | 827.53 | - | - | - | - | |
| Debt / Equity Ratio | 0.32 | 0.32 | 0.40 | 0.38 | 0.32 | 0.29 | |
| Debt / EBITDA Ratio | - | - | - | - | 6.33 | - | |
| Debt / FCF Ratio | 109.27 | 90.64 | - | - | - | - | |
| Asset Turnover | 0.01 | 0.02 | 0.02 | 0.02 | 0.11 | 0.07 | |
| Inventory Turnover | 1.25 | 2.55 | 1.90 | 1.26 | 2.06 | 1.95 | |
| Quick Ratio | 0.22 | 0.23 | 0.25 | 0.25 | 0.26 | 0.20 | |
| Current Ratio | 1.15 | 1.14 | 1.18 | 1.25 | 1.37 | 1.31 | |
| Return on Equity (ROE) | -4.82% | -5.60% | -6.35% | -9.12% | -1.08% | -86.06% | |
| Return on Assets (ROA) | -1.78% | -1.74% | -2.32% | -2.49% | 0.31% | -35.91% | |
| Return on Capital (ROIC) | -2.34% | -2.30% | -3.12% | -3.31% | 0.42% | -45.76% | |
| Return on Capital Employed (ROCE) | -3.50% | -3.40% | -5.10% | -5.40% | 0.60% | -104.40% | |
| Earnings Yield | -3.23% | -1.96% | -2.96% | -4.35% | -0.54% | -69.48% | |
| FCF Yield | - | 0.14% | -0.02% | -0.07% | -0.30% | -0.03% | |
| Buyback Yield / Dilution | 1.29% | - | - | - | - | - | |
| Total Shareholder Return | 1.29% | - | - | - | - | - | |
Source: S&P Capital IQ. Standard template.
Financial Sources.